GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells

Bladder cancer (BC) ranks as the sixth cancer in males and the ninth most common cancer worldwide. Conventional treatment modalities, including surgery, radiation, chemotherapy, and immunotherapy, have limited efficacy in certain advanced instances. The involvement of GALNT6-mediated aberrant O-glyc...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cancer cell international Ročník 24; číslo 1; s. 308 - 18
Hlavní autori:	Sun, Xiaoxin, Wu, Haotian, Tang, Ling, Al-Danakh, Abdullah, Jian, Yuli, Gong, Li, Li, Congchen, Yu, Xiao, Zeng, Guang, Chen, Qiwei, Yang, Deyong, Wang, Shujing
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 08.09.2024 Springer Nature B.V BMC
Predmet:	Antigens Bioinformatics Biomarkers Biomedical and Life Sciences Biomedicine Bladder cancer Cancer Research CD8 antigen Cell Biology Cell culture Chemotherapy Epithelial-mesenchymal transition GALNT6 Gene expression Genomes Glycosylation Immune evasion Immunotherapy Liver cancer Lymphocytes T Malignancy Medical prognosis Metastases Molecular modelling O-glycosylation Oncology Online data bases Polypeptides Prostate Tumor cells Tumor immune escape Tumor microenvironment Tumors GALNT6 Epithelial-mesenchymal transition O-glycosylation Tumor immune escape Bladder cancer
ISSN:	1475-2867, 1475-2867
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!